Atlas Trials

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Clinical trial NCT01399372 · COMPLETED

Trial details

NCT number
NCT01399372
Sponsor
Radiation Therapy Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapeutic Agent ToxicityCognitive/Functional EffectsLymphomaNeurotoxicityRadiation Toxicity
Start date
2011-09-01
Primary completion
2020-03-19
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.